An antiidiotypic antibody that recognizes the beta-adrenergic receptor.
AUTOR(ES)
Homcy, C J
RESUMO
Antialprenolol rabbit antibodies were fractionated on an acebutolol affinity resin, followed by L-propranolol elution so as to separate a class of binding sites that mimic the beta-adrenergic receptor. Allotype-identicaL rabbits were immunized with this fraction. After 6 mo, antisera exhibited antiidiotypic activity inhibiting [3H]alprenolol binding to the original antibody and to rabbit antiacebutolol antibodies, which had a spectrum of ligand-binding properties identical to the original idiotype. Those antisera demonstrating the original idiotype. Those antisera demonstrating the most potent antiidiotypic activity also blocked [3H]alprenolol binding to the beta-adrenergic receptor of turkey membrane, canine pulmonary membrane, and rat reticulocyte. An idiotype affinity-purified fraction showed similar activity, inhibiting beta-receptor binding with a calculated dissociation constant (KD) of 53 nM. Isoproterenol-mediated adenylate cyclase activity was also inhibited in a competitive manner. The universality of recognition of these antiidiotypic antisera indicate that the three-dimensional structure of a receptor's binding site can be modeled by a subset of an elicited antibody population.
ACESSO AO ARTIGO
http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=370179Documentos Relacionados
- Catecholamine binding to the beta-adrenergic receptor.
- beta-Adrenergic agonist activity of a monoclonal anti-idiotypic antibody.
- Iodoazidobenzylpindolol, a photoaffinity probe for the beta-adrenergic receptor.
- Hormone-receptor interactions are noncooperative: application to the beta-adrenergic receptor.
- Structural features required for ligand binding to the beta-adrenergic receptor.